Cardiology Conference | Cardiac Pharmacology 2019 | Cardiology Meeting | Pharmacology Symposium | Heart Congress | Cardiology Workshop | Asia Pacific | USA | Europe | Middle East | 2019 | 2020

cardiac Pharmacology conferences in Asia, cardiac Pharmacology congress in USA, cardiology societies, cardiology associations, Cardiovascular conferences in Asia, cardiovascular meetings, continuous cardia education credits, Euro cardiac pharmacology, w

Renowned Speakers

Joseph Kitzmiller

The Ohio State University USA

Subodh Verma

St Michaelâ€™s Hospital Canada

Tomasz M Kameczura

RzeszÃ³w Uniwersity, Poland Poland

Yoshiaki Omura

New York Medical College USA

Nassir Azimi

Sharp Grossmont Hospital USA

Nurul Islam

Ramakrishna Mission Seva Pratisthan India

Rajarshi Pal

Princess Margaret Hospital for Children Australia

Manuela Stoicescu

University of Oradea Romania

Recommended Global Cardiology Webinars & Conferences

Europe & UK

GERIATRIC CARDIOLOGY 2025, France Hypertension Congress-2025, France Interventional Cardiology 2025, UK Euro Cardiology Congress 2025, Italy Congestive Heart Failure-2025, Switzerland

Asia Pacific & Middle East

Canada

Clinical Cardiology 2025, Canada Heart Congress-2025, Canada Annual Cardiology 2025, Canada

Cardiac Pharmacology 2019

About Conference

Cardiac Pharmacology proudly announces the 6th Global Experts Meeting on Cardiovascular Pharmacology which will be held from July 26-27, 2019 in Kyoto, Japan. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists in Cardiac Pharmacology 2019. The theme of the conference Advancing into the Future of Heart Science and Pharmacology Medicine hosted by Conference Series LLC LTD.

Cardiac Pharmacology 2019 is focused on the importance to understand, to meet and share the knowledge with eminent persons related to the academy and towards the industrial knowledge and which comprises brief of keynote presentations, speaker talks, Exhibition, Symposia, and Workshops. This Heart Diseases Congress, cardiovascular conferences or rather all Cardiology meeting, cardiology events will help in frameworks organization, B2B teaming up amidst specialists and academicians. We have dealt with various compelling cardiology events and cardiology gatherings and develops incredible relations bringing the researchers and associations together. Cardiology conferences, cardiologist get-togethers and cardiology events are crucial for the essential people to think about the most basic bit of the human body.

Heart conferences are designed in a way to provide a varied education and present the latest technologies to keep medical professionals updated with present trends in the field of prevention, diagnosis and treatment of cardiac diseases.

Heart conferences are the best occasion to exhibit our technologies and get a better understanding of the practical challenges faced by physicians and patients in their daily life. The Global Cardiology conferences mainly focus on spreading the awareness about challenges in this field.

Why Attend???

Join your peers around the world focused on learning about Cardiac Pharmacology 2019 and related advances, which is your single best opportunity to reach the largest assemblage of participants from the Heart Diseases, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research work on cardiology, and receive name recognition at this 2 days event. World-renowned speakers, the most recent research, advances, and the newest updates in Cardiac Pharmacology 2019 are hallmarks of this conference.

Lectures from renowned speakers
Keynote forums by Prominent Professors, Doctors
Open Innovation Challenges
Poster presentations by Young Researchers
Global Networking sessions with 50+ Countries
Novel techniques to benefit your research
Best platform for Global business and Networking opportunities
Meet the editors of refereed journals, Society and Association members across the Globe
Excellent platform to showcase the latest products and formulations in Cardiac field

Advertise Analysis:

The World Heart Federation (WHF) joins 200 people navigating 100 countries in the fight against cardiovascular sickness Global Data inquire about predicts the general business division for CMD contraptions will reach $1.2 billion by 2017. The overall cardiovascular contraption industry is turning out to be rapidly and is said that an advancement of $15billion is created utilizing 2010-2015 as indicated by BCC examine. Items fused into this business part are electrocardiograph watching outfit, which is set to see 4% improvement by 2017 to be worth over $410 million The overall cardiovascular device industry is turning out to be rapidly and gives suggestions that it will continue progressing and develop to reach over $97 billion by 2017, up from just about $85 billion in 2010.

Target Audience:

Cardiac Surgeons
University Professors
Research Scholars
Business Entrepreneurs
Data Management
Medical Colleges
Cardiology Fellows
Cardiology Students, Scientists
Training Institutes
Manufacturing Medical Devices Companies
Software making associations

Session and Tracks

Track 1. Cardiology - Future Medicine

Cardiology is a branch of medicine which deals with disorders of the heart as well as parts of the circulatory system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. It is likely that there will be continuing sub-specialization in the pursuit of technical virtuosity and clinical excellence in the field of cardiology. This situation will at first both aggravate the escalation of costs and intensify the workforce shortage.

Sub Tracks:

Development of Pacemaking and Cardiac Conduction System lineages
Role of platelets and antiplatelet therapy in cardiovascular disease
Molecular targets of antihypertensive drug therapy
Personalized medicine in cardiology
Real-world evidence and outcomes research

Related Conferences:

Related Societies:

Indonesian Heart Association, Hong Kong College of Cardiology, Hong Kong Society of Paediatric Cardiology, Mongolian Society for Pediatric Cardiology, National Heart Association of Malaysia, Philippine Heart Association, Singapore Cardiac Society. The Asian Pacific Society of Cardiology | |European Society of Cardiology|| Asian Pacific Society of Interventional Cardiology Heart Asia | Heart Asia aims to convey the best cardiology research | 10Th Asian Society of Cardiovascular Imaging Congress | American of Cardiology Asia Conference | Asian Heart Institute| Philippine Heart Center | Irish Cardiac Society| International Outreach - Society for Cardiovascular Magnetic Resonance| Society for Cardiovascular Angiography and Interventions (SCAI)|North American Society for Cardiovascular Imaging: NASCI| Sri Jayadeva Institute of Cardiology| Asian Federation Of Cardiology - afcc.org| Paediatric Cardiology| Nuclear Cardiology Practice in Asia: Analysis of Radiation Exposure| Society of Cardiovascular Anesthesiologists| Dr. Rishi Gupta - Interventional Cardiologist in Faridabad| Asian Pacific Society of Cardiology & Heart Disease.

EUROPE SOCIETIES: European Society of Cardiology| ESC Member National |Cardiac Societies |ESC Affiliated Cardiac Societies| European Society of Cardiology Atlas of Cardiology| The National Cardiac Societies of the European Society of Cardiology| European Association for Clinical Pharmacology and Therapeutics| European Journal of Pharmacology| The Cardiovascular & Respiratory Pharmacology Affinity Group| International Society of Cardiovascular Pharmacotherapy – ISC| Pharmacotherapeutic management of paediatric heart failure and ACE| Advanced Cardiovascular Pharmacology: Associations & Soc| European Guidelines on cardiovascular disease prevention in clinical practice| Pharmacology behind Common Drug Nephrotoxicity |

USA SOCIETIES: Indian - International Society for Heart Research| American College of Cardiology| ISHLT: The International Society for Heart & Lung Transplantation| The Diplomate in Safety Pharmacology (DSP) certification| ACC 2019 - American Congress of Cardiology| ASPET | Division for Cardiovascular Pharmacology (CVP)

Track 2. Anaesthesia and Cardiac Image

General anaesthesia for cardiac MRI is governed by similar principles for any anaesthetic technique in children with heart disease. High-risk imaging refers to imaging in patients with medical or health-related risks, imaging with equipment-related risks, and procedure-related risks such as MRI-guided surgery, minimally invasive procedures. MRI can be performed in patients who have undergone previous cardiac surgery. Absolute contraindications include patients with pacemakers and defibrillators. A Deep sedation or general anaesthesia is indicated in neonates, infants and small children for MRI. The challenges during MRI include limited access to patient and equipment, low ambient temperature with risk for hypothermia and a noisy unfamiliar environment with the remote location from the operating room. Anaesthetic care for magnetic resonance imaging (MRI) as moderate sedation, deep sedation, monitored anaesthesia care, general anaesthesia, or ventilatory and critical care support.

Sub Tracks:

Morphology
Cardiac MR imaging
Neurological effects
CT radiation risk

Related Conferences:

Related Societies:

The Asian Pacific Society of Cardiology | |European Society of Cardiology|| Asian Pacific Society of Interventional Cardiology Heart Asia | Heart Asia aims to convey the best cardiology research | 10Th Asian Society of Cardiovascular Imaging Congress | American of Cardiology Asia Conference | Asian Heart Institute| Philippine Heart Center | Irish Cardiac Society| International Outreach - Society for Cardiovascular Magnetic Resonance| Society for Cardiovascular Angiography and Interventions (SCAI)|North American Society for Cardiovascular Imaging: NASCI| Sri Jayadeva Institute of Cardiology| Asian Federation Of Cardiology - afcc.org| Paediatric Cardiology| Nuclear Cardiology Practice in Asia: Analysis of Radiation Exposure| Society of Cardiovascular Anesthesiologists| Dr. Rishi Gupta - Interventional Cardiologist in Faridabad| Asian Pacific Society of Cardiology & Heart Disease.

Track 3. Heart - Surgery & Transplantation

A heart transplant is a treatment that's usually reserved for people this is a treatment option for people who are in the end stages of heart failure, but their conditions haven't sufficiently improved. 90% of heart transplants are performed on patients with end-stage heart failure. A heart transplant is an operation in which the diseased heart in a person is replaced with a healthy heart from a deceased donor. The first heart transplant patient survived only 18 days, four of Groote Schuur Hospital’s first 10 patients survived for more than one year, two living for 13 and 23 years, respectively. Clinical research studies are designed to answer specific questions, sometimes about a new drug or medical device's safety and effectiveness. Rejection is the most common cause of the donor's heart failing in heart transplant patients. If the transplanted heart fails, the patient dies.

Sub Tracks:

heart failure
Coronary heart disease
Pulmonary hypertension
Organ Procurement and Transplantation Network
Donor Heart

Related Conferences:

Related Societies:

Asian Pacific Society of Cardiology, Asian Pacific Society of Hypertension, Asian Society for Cardiovascular and Thoracic Surgery, Asian Society of Cardiothoracic Anaesthesia, Asian Society of Cardiovascular Imaging, Association of Black Cardiologists, Association of Cardiologists of Kazakhstan, Association of Pediatric Cardiology, Association of Thoracic and Cardiovascular Surgeons of Asia (ATCA), Australian Cardiovascular Health and Rehabilitation Association.

EUROPE SOCIETIES: European Society of Cardiology| ESC Member National |Cardiac Societies |ESC Affiliated Cardiac Societies| European Society of Cardiology Atlas of Cardiology| The National Cardiac Societies of the European Society of Cardiology| European Association for Clinical Pharmacology and Therapeutics| European Journal of Pharmacology| The Cardiovascular & Respiratory Pharmacology Affinity Group| International Society of Cardiovascular Pharmacotherapy – ISC| Pharmacotherapeutic management of paediatric heart failure and ACE| Advanced Cardiovascular Pharmacology: Associations & Soc| European Guidelines on cardiovascular disease prevention in clinical practice| Pharmacology behind Common Drug Nephrotoxicity |

USA SOCIETIES: Indian - International Society for Heart Research| American College of Cardiology| The International Society for Heart & Lung Transplantation| The Diplomate in Safety Pharmacology (DSP) certification| ACC 2019 - American Congress of Cardiology| ASPET | Division for Cardiovascular Pharmacology (CVP)

Track 4. Insulin pumps and Therapy

Continuous subcutaneous insulin infusion (CSII) using an external pump, offers both a better blood glucose stability as compared to multiple daily injections and a broader flexibility in life mode and reduces the frequency of severe hypoglycemia. An insulin pump is a small device about the size of a small cell phone that is worn externally and can be discreetly clipped to your belt, slipped into a pocket, or hidden under your clothes. Advances in technology have allowed individuals with diabetes a choice in insulin delivery methods: MDI or CSII. Insulin pump therapy is an increasingly popular method of insulin replacement therapy. Because the insulin delivery from insulin pumps can more closely mimic what your body does naturally, you can improve your blood sugar control.

Sub Tracks:

Genetic link of Diabetes
Obesity and Heart
Obesity & Cancer
Glucose Monitoring
Hypoglycemia

Related Conferences:

Scripps 5th Annual Clinical Advances in Arrhythmias and Heart Failure April 27-29, 2018 La Jolla, USA; Arteriosclerosis, Thrombosis and Vascular Biology: Peripheral Vascular Disease 2018 Scientific Sessions May 04-06, 2018 Minneapolis, USA; 19th Annual American Society of Echocardiography eXAM/ReASCE Review Course May 05-08, 2018 Boston, USA; Heart Rhythm Scientific Sessions May 09-12, 2018 Boston, USA; Echo Asia 2018 May 24-27, 2018 Korea; Society of Cardiovascular Computed Tomography SCCT2018 - 13th Annual Scientific Meeting July 12-15, 2018 Texas, USA; 34th World Congress of Internal Medicine October 18-21, 2018 Cape Town, South Africa.

Related Societies:

Cardiac Society of Australia & New Zealand, Cardiological Society of India, Chinese Society of Cardiology, Chinese Society of Cardiology, Indonesian Heart Association, Hong Kong College of Cardiology. The Asian Pacific Society of Cardiology | |European Society of Cardiology|| Asian Pacific Society of Interventional Cardiology Heart Asia | Heart Asia aims to convey the best cardiology research | 10Th Asian Society of Cardiovascular Imaging Congress | American of Cardiology Asia Conference | Asian Heart Institute| Philippine Heart Center | Irish Cardiac Society| International Outreach - Society for Cardiovascular Magnetic Resonance| Society for Cardiovascular Angiography and Interventions (SCAI)|North American Society for Cardiovascular Imaging: NASCI| Sri Jayadeva Institute of Cardiology| Asian Federation Of Cardiology - afcc.org| Paediatric Cardiology| Nuclear Cardiology Practice in Asia: Analysis of Radiation Exposure| Society of Cardiovascular Anesthesiologists| Dr. Rishi Gupta - Interventional Cardiologist in Faridabad| Asian Pacific Society of Cardiology & Heart Disease.

USA SOCIETIES: Indian - International Society for Heart Research| American College of Cardiology| ISHLT: The International Society for Heart & Lung Transplantation| The Diplomate in Safety Pharmacology (DSP) certification| ACC 2019 - American Congress of Cardiology| ASPET | Division for Cardiovascular Pharmacology (CVP)

Track 5. Cardiac Surgery

Cardiac surgery, or cardiovascular surgery, is surgery performed on the heart or blood vessels by cardiac surgeons. It is often used to treat complications of ischemic heart diseases like coronary artery bypass grafting, to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. It also includes heart transplantation.

Sub Tracks:

Minimally invasive coronary artery bypass surgery
Valve-sparing aortic root replacement
Open heart surgery
Transmyocardial laser revascularization
Off-pump heart surgery

Related Conferences:

Related Societies:

Track 6. Cardiac Pharmacology

Cardiac Society of Australia & New Zealand, Cardiological Society of India, Chinese Society of Cardiology, Chinese Society of Cardiology, Indonesian Heart Association, Hong Kong College of Cardiology. Cardiovascular pharmacology deals with the medication of cardiac diseases. The Cardiac Drugs are used to treat conditions of the heart or the circulatory or vascular system. Many classes of cardiovascular agents are available to treat the various cardiovascular conditions. In this subtopic, we have Sodium, potassium, calcium channel blockers, ACE-inhibitors and Cardiac Biomarkers.

Cardiovascular drugs
Drug Discovery
Cardiac Medications

Related Conferences:

Related Societies:

Association of Pediatric Cardiology, Association of Thoracic and Cardiovascular Surgeons of Asia (ATCA), Australian Cardiovascular Health and Rehabilitation Association, Cardiac Society of Australia & New Zealand, Cardiological Society of India, Chinese Society of Cardiology, Chinese Society of Cardiology.

Track 7. Industrial aspects on Cardiology

This chapter presents some preliminary findings and hypotheses drawn from field interviews with key participants who are involved in the innovation process in two important and widely used technologies that provide diagnostic information about the heart. It provides a forum for original and reviews articles related to experimental cardiology that meet its stringent scientific standards. Analysis of this tentative model of the innovation process helped us to identify some points of leverage for increasing the rate and sharpening the focus of innovation. We discuss how these levers could productively stimulate changes in managerial and public policy. If much of what will transpire over the course of a day involves the use of various medical products, then what is needed are methods by which there can be a knowledge transfer (education) between the industry and cardiovascular clinicians. Much of the progress in cardiology during the 20th century was made possible by improved diagnostic tools.

Sub Tracks:

Antibiotic Resistance
Clinical trials in Cardiology
Current Research in Cardiology
Cardiac and Cardiovascular Research

Related Conferences:

Related Societies:

Track 8. Angiography & Cardiac Surgery

The present study compared the clinical prediction of the effect of coronary artery bypass grafting (CABG) on coronary blood flow and left ventricular ejection fraction (LVEF) with changes in gated myocardial perfusion scintigraphy. Our clinical prediction models could enhance the identification of patients at low risk of the significant CAD for whom CCA might potentially be avoided before cardiac surgery. Minimally invasive coronary artery bypass grafting is safe, feasible, and associated with excellent outcomes and graft patency at 6 months post-surgery. To determine if coronary computed tomographic angiography enhances prediction of perioperative risk in patients before non-cardiac surgery and to assess the preoperative coronary anatomy in patients who experience a myocardial infarction after non-cardiac surgery.

Sub Tracks:

Coronary Angiography
Angioplasty
Electrocardiography
Heart catheterization
Coronary artery bypass grafting

Related Conferences:

Related Societies:

Association of Cardiologists of Kazakhstan, Association of Pediatric Cardiology, Association of Thoracic and Cardiovascular Surgeons of Asia (ATCA), Australian Cardiovascular Health and Rehabilitation Association.

Track 9. Epidemiology and Public Health

Epidemiology is often considered the key scientific underpinning of public health practice. Epidemiology is the study of disease in populations. Veterinarians and others involved in the preventive medicine and public health professions use epidemiological methods for disease surveillance, outbreak investigation, and observational studies to identify risk factors of zoonotic disease in both human and animal populations. Epidemiology is often considered the key scientific underpinning of public health practice this commentary examines the scope of epidemiology and delineates the role of epidemiology in relation to public health.

Sub Tracks:

AIDS
Rabies
Water-borne illnesses
Vibrio vulnificus
Biostatistics
Public Health Sciences
Global Health

Related Conferences:

American College of Cardiology’s 67th Annual Scientific Session & Expo March 10-12, 2018 Orlando, USA; European Heart Rhythm Association (EHRA) March 18-20, 2018 Barcelona, Spain; Japanese Circulation Society 82nd Annual Scientific Meeting March 23-25, 2018 Osaka, Japan; German Society of Cardiology 84th Annual Meeting April 04-07, 2018 Mannheim, Germany; Frontiers in Cardiovascular Biology April 20-22, 2018 Vienna, Austria; 12th World Congress of the World Federation of Nuclear Medicine and Biology April 20-24, 2018 Melbourne, Australia; Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessions April 25-28, 2018 San Diego, USA; Scripps 5th Annual Clinical Advances in Arrhythmias and Heart Failure April 27-29, 2018 La Jolla, USA.

Related Societies:

Track 10. Diabetes & Cardiovascular Engineering

Diabetes is a disease in which your blood glucose, or blood sugar, levels are too high. Glucose comes from the foods you eat. Insulin is a hormone that helps the glucose get into your cells to give them energy. Cardiovascular Engineering: An International Journal is a publishing forum that promotes innovative methods and technological advancements in the basic understanding of the cardiovascular system and in cardiovascular diagnosis and treatment applications. Cardiovascular solid mechanics work addresses the mechanical properties and stresses in healthy and diseased arterial cross sections and examines the role of mechanical factors in the disruption of atherosclerotic plaques.

Sub Tracks:

Diabetes mellitus
Heart Otago
Cardiovascular and respiratory physiology
Translational Physiology

Related Conferences:

Frontiers in Cardiovascular Biology April 20-22, 2018 Vienna, Austria; 12th World Congress of the World Federation of Nuclear Medicine and Biology April 20-24, 2018 Melbourne, Australia; Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessions April 25-28, 2018 San Diego, USA; Scripps 5th Annual Clinical Advances in Arrhythmias and Heart Failure April 27-29, 2018 La Jolla, USA; Arteriosclerosis, Thrombosis and Vascular Biology: Peripheral Vascular Disease 2018 Scientific Sessions May 04-06, 2018 Minneapolis, USA; 19th Annual American Society of Echocardiography eXAM/ReASCE Review Course May 05-08, 2018 Boston, USA; Heart Rhythm Scientific Sessions May 09-12, 2018 Boston, USA.

Related Societies:

Track 11. Vascular Biology

Our vascular biology research focuses largely on diseases of the aorta and diseases involving leaky blood vessels, including age-related macular degeneration, peripheral vascular disease, stroke and solid tumour growth. The vascular network consists of both small and large vessels specifically designed to accommodate varying levels of blood flow and pressure, depending upon the location within the body.

Sub Tracks:

Arrhythmia & EP
Thrombosis
Lymphoma
Blood sugar
Anemia

Related Conferences:

American Society of Echocardiography 28th Annual Echo Hawaii 2018 January 15-19, 2018 Hawaii, USA; Mayo Clinic Cardiovascular Reviews in Bahrain January 16-20, 2018 Manama, Bahrain; 28th European Days of The French Society of Cardiology January 17-20, 2018 Paris, France; Malaysian Society of Hypertension 15th Annual Scientific Meeting January 19-21, 2018 Kuala Lumpur, Malaysia; Asia PCR 2018 January 24-27, 2018 Suntec City, Singapore; Gulf Arrhythmia Congress 2018 January 25-27, 2018 Dubai, UAE; Mayo Clinic updates in Cardio-Oncology 2018: Challenges and New Frontiers February 01-03, 2018 Scottsdale, USA; Belgian Society of Cardiology 37th Annual Scientific Meeting February 07-08, 2018 Brussels, Belgium; 27th Annual Cardiovascular Conference February 10-14, 2018 Avon, USA.

Related Societies:

Track 12. Women & Pediatric Cardiology

The pathophysiology of essential hypertension in men and women remains under investigation and the mechanisms responsible for the sexual dimorphism in blood pressure control are unclear. Sex-specific hemodynamic characteristics and the influence of sex hormones may account for some of the differences. Studies of the effects on blood pressure of menopausal hormone therapy have yielded conflicting results. In the WHI, women using hormone replacement therapy had a lower prevalence of hypertension (35%) than never users (41%), but users tended to be younger and thinner. After adjustment for these and other potentially confounding variables, the current use of hormone replacement therapy was associated with a 25% increase in the risk of hypertension compared with never use or past use. The pediatric cardiology and congenital heart disease have experienced considerable progress in the last few years, with advances in new diagnostic and therapeutic techniques that can be applied at all stages of life from the fetus to the adult.

Sub Tracks:

Obesity & Cancer
Myocardial Infarction
Silent Ischemia
Coronary Artery Disease
Peripheral Arterial Disease
Pediatric obesity and CHD risk

Related Conferences:

Related Societies:

Hong Kong Society of Paediatric Cardiology, Mongolian Society for Pediatric Cardiology, National Heart Association of Malaysia, Philippine Heart Association, Singapore Cardiac Society, Singapore National Heart Association, Taiwan Society of Cardiology, The Korean Society of Cardiology, The Pan-African Society of Cardiology (PASCAR), Vietnam Heart Association, World Health Organization.

Track 13. Pediatric & Fetal Cardiology

Expert fetal cardiac evaluation is performed using superior ultrasound machinery with the highest resolution imaging available, including 2D and Doppler analysis, as well as 3D and 4D technology. Initial detection of cancer in children also is taking earlier attention in Clinical Pediatrics cancer. This allows us to perform first-trimester screening so that patients can be referred at the earliest stages of pregnancy. Clinical Pediatrics allergy is also one of the most important and widely studied areas in novel research of this field, Clinical Pediatrics is a medical journal that follows to child-centre care, the clinical, scientific, behavioural, educational, or ethical nature. The Fetal Cardiology Program offers evaluation, diagnosis and management of pregnancies at risk for fetal structural heart defects and rhythm disturbances.

Sub Tracks:

Fetal echo
Congenital Heart Disease
Fetal Echocardiography
Fetal Echocardiography

Related Conferences:

American Society of Echocardiography 31st Annual State-of-the-art Echocardiography February 17-20, 2018 San Diego, USA; 5th International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome February 22-25, 2018 Venice, Italy; National Lipid Association Clinical Lipid Update Spring February 23-25, 2018 San Antonio, USA; 15th Annual Vascular Innovations Conference February 23-24, 2018 Troy, USA; Egyptian Society of Cardiology 45th Annual Conference February 26-MARCH 1, 2018 Cairo, Egypt; Arrhythmias and the Heart: A Cardiovascular Update February 26 - March 02, 2018 Koloa, USA; European Society of Cardiology Acute Cardiovascular Care March 03-05, 2018 Milan, Italy.

Related Societies:

Taiwan Society of Cardiology, The Korean Society of Cardiology, The Pan-African Society of Cardiology (PASCAR), Vietnam Heart Association, World Health Organization.

The Asian Pacific Society of Cardiology | |European Society of Cardiology|| Asian Pacific Society of Interventional Cardiology Heart Asia | Heart Asia aims to convey the best cardiology research | 10Th Asian Society of Cardiovascular Imaging Congress | American of Cardiology Asia Conference | Asian Heart Institute| Philippine Heart Center | Irish Cardiac Society| International Outreach - Society for Cardiovascular Magnetic Resonance| Society for Cardiovascular Angiography and Interventions (SCAI)|North American Society for Cardiovascular Imaging: NASCI| Sri Jayadeva Institute of Cardiology| Asian Federation of Cardiology - afcc.org| Paediatric Cardiology| Nuclear Cardiology Practice in Asia: Analysis of Radiation Exposure| Society of Cardiovascular Anesthesiologists| Dr. Rishi Gupta - Interventional Cardiologist in Faridabad| Asian Pacific Society of Cardiology & Heart Disease.

Track 14. Cardiovascular Pharmacology and Toxicology

Cardiovascular toxicology may be caused due to chemotherapy or due to the medication for the treatment of heart diseases. Cardiovascular Pharmacology deals with the study of drug action which exerts a biochemical or physiological effect on the tissue, cell, organ or organism. The interactions affect normal or abnormal biochemical function. The cardiovascular group is studying the connections between salt intake or obesity on blood pressure control mechanisms. These investigators use state of the art molecular, cellular and integrative approaches to study the vascular function and neural control of blood pressure.

Sub Tracks:

Neurotoxicology
Drug addiction and alcohol dependence
Neurodegenerative disorders
Circadian rhythm disorders

Related Conferences:

15th Annual Vascular Innovations Conference February 23-24, 2018 Troy, USA; Egyptian Society of Cardiology 45th Annual Conference February 26-MARCH 1, 2018 Cairo, Egypt; Arrhythmias and the Heart: A Cardiovascular UpdateFebruary 26 - March 02, 2018 Koloa, USA; European Society of Cardiology Acute Cardiovascular Care March 03-05, 2018 Milan, Italy; American College of Cardiology’s 67th Annual Scientific Session & Expo March 10-12, 2018 Orlando, USA; European Heart Rhythm Association (EHRA) March 18-20, 2018 Barcelona, Spain; Japanese Circulation Society 82nd Annual Scientific Meeting March 23-25, 2018 Osaka, Japan; German Society of Cardiology 84th Annual Meeting April 04-07, 2018 Mannheim, Germany.

Related Societies:

Track 15. Heart Diseases and Cardiac Arrest

Heart attack mistakenly refers to cardiac arrest, but heart attacks are caused by a blockage that stops the blood supply to the heart. This is because a person who is having a heart attack may develop a dangerous heart rhythm, which can cause a cardiac arrest. Cardiac arrest refers to the disruption of heart function that is the malfunction of an electrical system of the heart. This analysis demonstrates that the annual NIH investment in CA research is low relative to other leading causes of death in the United States and has declined over the past decade. Many cardiac arrests in adults happen because of a heart attack. Sudden cardiac death (SCD) from cardiac arrest is a major international public health problem accounting for an estimated 15–20% of all deaths; it is a leading cause of death in the United States.

Sub Tracks:

Hypertrophic cardiomyopathy
Methamphetamine
Sudden cardiac arrest
Implantable cardiac defibrillator

Related Conferences:

Gulf Arrhythmia Congress 2018 January 25-27, 2018 Dubai, UAE; Mayo Clinic updates in Cardio-Oncology 2018: Challenges and New Frontiers February 01-03, 2018 Scottsdale, USA; Belgian Society of Cardiology 37th Annual Scientific Meeting February 07-08, 2018 Brussels, Belgium; 27th Annual Cardiovascular Conference February 10-14, 2018 Avon, USA; American Society of Echocardiography 31st Annual State-of-the-art EchocardiographyFebruary 17-20, 2018 San Diego, USA; 5th International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome February 22-25, 2018 Venice, Italy; National Lipid Association Clinical Lipid Update Spring February 23-25, 2018 San Antonio, USA.

Related Societies:

Singapore National Heart Association, Taiwan Society of Cardiology, The Korean Society of Cardiology, The Pan-African Society of Cardiology (PASCAR), Vietnam Heart Association, World Health Organization.

Track 16. Nutrition, Diet & Exercise

A healthy diet and lifestyle are our best weapons to fight cardiovascular disease, Regular exercise builds lean muscle, which burns more calories than fat When combined with a healthy diet, exercise can speed up weight loss. it's the overall pattern of our choices that counts. Some of the barriers and facilitators identified by young people had been addressed by soundly evaluated effective interventions, the prevalence of physical inactivity among 51% of adult Canadians is higher than that of all other modifiable risk factors, but significant gaps were identified where no evaluated interventions appear to have been published (e.g. better labelling of food products), or where there were no methodologically sound evaluations. Exercise can also lower blood pressure. It reduces your risk of heart disease and reduces levels of LDL “bad” cholesterol. DASH (Dietary Approaches to Stop Hypertension), which helps to lower blood pressure, or TLC (Therapeutic Lifestyle Changes), which focuses on lowering our cholesterol levels. This helps it pump more blood with each heartbeat. This delivers more oxygen to our body. With more oxygen, our body functions more efficiently. Physical inactivity is a modifiable risk factor for cardiovascular disease and a widening variety of other chronic diseases, including diabetes mellitus, cancer colon and breast, obesity, hypertension, bone and joint diseases osteoporosis and osteoarthritis, and depression. Rigorous evaluation is required particularly to assess the effectiveness of increasing the availability of affordable healthy food in the public and private spaces occupied by young people. Lack of exercise, a poor diet and other unhealthy habits can take their toll over the years Exercise makes your heart stronger.

Sub Tracks:

Alternative Medicine
Alcohol
Childhood and Adolescent Obesity
Fitness, Sports, and Sports Nutrition
Herbal Information & Heart Health

Related Conferences:

Arteriosclerosis, Thrombosis and Vascular Biology: Peripheral Vascular Disease 2018 Scientific Sessions May 04-06, 2018 Minneapolis, USA; 19th Annual American Society of Echocardiography eXAM/ReASCE Review Course May 05-08, 2018 Boston, USA; Heart Rhythm Scientific Sessions May 09-12, 2018 Boston, USA; Echo Asia 2018 May 24-27, 2018 Korea; Society of Cardiovascular Computed Tomography SCCT2018 - 13th Annual Scientific Meeting July 12-15, 2018 Texas, USA; 34th World Congress of Internal Medicine October 18-21, 2018 Cape Town, South Africa.

Related Societies:

Track 17. Diabetes, Obesity & Stroke in Children

Childhood obesity is the most prevalent nutritional disorder among children and adolescents worldwide. Overweight and obese children are more likely to stay obese into adulthood and to develop noncommunicable diseases (NCDs) like diabetes and cardiovascular diseases at a younger age. Having diabetes or pre-diabetes puts one at increased risk for heart disease and stroke. Childhood obesity is associated with a higher chance of premature death & disability in adulthood. One can lower its risk by keeping the blood glucose (also called blood sugar), blood pressure, and blood cholesterol close to the recommended target numbers—the levels suggested by diabetes experts for good health. Stroke and coronary heart disease can be caused by the same problem –atherosclerosis. For most NCDs resulting from obesity, the risks depend partly on the age of onset and on the duration of obesity. The prevalence of obesity is highest among specific ethnic groups. Obesity increases the risk of heart diseases in children and adults. Childhood obesity predisposes the individual to insulin resistance and type 2 diabetes, hypertension, hyperlipidemia, liver and kidney diseases and causes reproductive dysfunction in adults.

Sub Tracks:

Convenience foods and obesity
Weight Flux
Dyslipidemia
Hyperinsulinemia
Electrocardiography

Related Conferences:

American Society of Echocardiography 31st Annual State-of-the-art Echocardiography February 17-20, 2018 San Diego, USA; 5th International Conference on Prehypertension, Hypertension and Cardio Metabolic SyndromeFebruary 22-25, 2018 Venice, Italy; National Lipid Association Clinical Lipid Update Spring February 23-25, 2018 San Antonio, USA; 15th Annual Vascular Innovations Conference February 23-24, 2018 Troy, USA; Egyptian Society of Cardiology 45th Annual Conference February 26-MARCH 1, 2018 Cairo, Egypt; Arrhythmias and the Heart: A Cardiovascular Update February 26 - March 02, 2018 Koloa, USA; European Society of Cardiology Acute Cardiovascular Care March 03-05, 2018 Milan, Italy.

Related Societies:

Past Conference

Cardiovascular 2017

In the presence of interprofessional researchers and practitioners involved in the development of high-quality education in all aspects of clinical skills, Conference Series 2nd International Conference on Cardiovascular Medicine and Cardiac Surgery were held during March 15-16, 2017 in London, UK.

Conference Series Group played host to a diverse panel of key members of the Cardiovascular 2017 community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology and Cardiovascular specialities. This event was really aimed for examining where the real cardio-logical specialities are going in the future and purpose of the event was to provide an opportunity for cross-fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Cardiologists, Pediatric Cardiology, Heart Diseases, Echocardiography, Interventional Cardiology, Heart and Blood Vessel Surgeries, Cardiac Nursing, Diabetes, Cardiovascular Medicine, Cardiac Surgeries and the Heart and Heart Failure as well, the two days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by Honorable Guests and members of the Keynote forum. The highlights of the meeting were the eponymous lectures, delivered by:

William J Rowe from Medical University of Ohio, USA

Lingfang Zeng from King’s College London, UK

Ahmed N. Ghanem from Retired Consultant Urologist Egypt

Qiuping Zhang from King’s College London UK

Sunny Po from University of Oklahoma Health Sciences Center USA

Yanggan Wang from Wuhan University China

These talks were of great interest to the general cardiologists and were enormously informative.

Conference series LLC 2nd International Conference was a great success with the support of international, multi-professional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access. We are happy to announce our 6th Global Experts Meeting on Cardiovascular Pharmacology July 12-13, 2019, Yokohama, Japan.

Cardiology Conferences| Cardiologists Meetings | Cardiology Conferences Europe

Market Analysis

Market Analysis Report

As per the study conducted by Global Burden of Diseases estimate that the death rate due to cardiovascular diseases is 235 per 100000 in global population. According to World Health Organisation (WHO), cardiovascular diseases account for 31% deaths globally which is approximately 17.7 million individuals. Out of these 80% of the cardio vascular diseases deaths are due to stroke and heart attacks. Factors such as sedentary lifestyle, excess consumption of alcohol, stress, unhealthy eating habits, smoking are all factors responsible for the increase in the number of cardiovascular disorders among young population too.

Global Cardiovascular Drugs Market: Key Segments

It is identified that the global cardiovascular drugs market is basically segmented into beta-blockers, renin-angiotensin system blockers, anti-clotting agents, antihyperlipidemics, other antihypertensive, diuretics, calcium channel blockers and others by basing on drug class. The renin-angiotensin system blockers segment is again categorized into angiotensin receptor blockers and ACE inhibitors & the anti-clotting agents segment is further segmented into platelet aggregation inhibitors and anti-coagulants.

The drug class segments have been considered based on incidence of diseases, alertness regarding early diagnosis and presence of key players in the region. The market scope and forecast for all of these segments have been provided for the period from 2015 to 2025, along with their respective compound annual growth rates (CAGRs) for the forecast period from 2017 to 2025, taking 2016 as the base year.

Global Cardiovascular Procedures report details the current and projected surgical and interventional therapeutic procedures commonly used in the management of acute and chronic conditions affecting myocardium and vascular system.